MedTrace Logo

Central Serous Chorioretinopathy: Etiology, Course and Prognosis

NCT01378130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2013-04-26

No results posted yet for this study

Summary

Pathogenesis of central serous chorioretinopathy is not entirely understood yet, therefore further investigations are needed. During this study patients with an acute episode of central serous chorioretinopathy are observed with established ophthalmologic methods (multimodal imagine) every 6 weeks until subretinal fluid is reabsorbed to gain further insides in etiology, course and prognosis of this disease.

Conditions

  • Central Serous Chorioretinopathy

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Stefan Sacu, Ass.Prof.Dr. · Department of Ophthalmology, Medical University of Vienna, Austria

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01378130 on ClinicalTrials.gov